THG-008

N/A

Report date: 2026/02/04 11:11:36
NME

Base Information

Drug NameTHG-008
Drug Alias Name[18F]PARPiBDC-003THG-008ATD001ATD-001
ClassificationSmall molecules > Heterocyclic drugsRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Radioactive diagnostic agent +[5] 
Mechanisms of ActionPoly (ADP-Ribose) polymerase inhibitorsPositron-emission tomography enhancers
TargetsPoly (ADP-Ribose) polymerase
Therapy Area/IndicationsBrain NeoplasmsHead and Neck Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesMemorial Sloan Kettering Cancer Center
China Registration ClassN/A

Develop Information

Active CompaniesTheragnosticsMemorial Sloan Kettering Cancer Center
Inactive CompaniesN/A
Active IndicationsBrain NeoplasmsHead and Neck Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A